Consolidated figures
| Ratio | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Margins | ||||
| Gross margin % | 15.8% | 17.7% | 16.3% | 14.9% |
| EBITDA margin % | -2.1% | 0.9% | ||
| -0.3% |
| 0.5% |
| EBIT margin % | -4.4% | -1.2% | -2.4% | -0.9% |
| PAT margin % | -4.1% | -0.2% | 0.3% | -0.8% |
| Working capital | ||||
| Receivable days | 16 | 10 | 8 | 5 |
| Inventory days | 142 | 162 | 132 | 123 |
| Payable days | 16 | 11 | 20 | 16 |
| NWC days | 142 | 161 | 120 | 112 |
| Leverage | ||||
| Current ratio | 1.68 | 1.57 | 1.41 | 1.4 |
| Debt to EBITDA | — | 38.31 | — | 54.71 |
| Debt to equity | 0.89 | 0.8 | 0.74 | 0.7 |
| Interest coverage | -2.4 | 1.1 | -0.1 | 0.5 |
| Asset turnover | 1.46 | 1.2 | 1.26 | 1.35 |
| Return ratios | ||||
| Return on assets % | -6% | -0.2% | 0.4% | -1.1% |
| Return on capital employed % | -8.5% | 5.8% | -0.5% | 2.9% |
| Return on equity % | -12.3% | -0.4% | 0.7% | -2% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.